Calumet Specialty Products Partners - CLMT Stock Forecast, Price & News

Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. Its Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The company's Montana/Renewables segment focuses on processing renewable feedstocks into renewable hydrogen, renewable natural gas, renewable propane, renewable naphtha, renewable kerosene/aviation fuel, and renewable diesel. This segment also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. Its Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.

Calumet Specialty Products Partners Price Performance

Shares of NASDAQ:CLMT traded down $0.21 during midday trading on Monday, hitting $16.27. 193,514 shares of the company's stock were exchanged, compared to its average volume of 177,727. The stock's 50 day moving average price is $12.01 and its 200-day moving average price is $13.43. The firm has a market cap of $1.29 billion, a P/E ratio of -9.01 and a beta of 2.19. Calumet Specialty Products Partners has a twelve month low of $5.40 and a twelve month high of $17.43.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on CLMT. StockNews.com raised Calumet Specialty Products Partners from a "sell" rating to a "hold" rating in a report on Friday, May 13th. Cowen boosted their price objective on Calumet Specialty Products Partners from $18.00 to $20.00 and gave the company an "outperform" rating in a report on Tuesday, June 28th. Finally, Wells Fargo & Company boosted their price objective on Calumet Specialty Products Partners from $27.00 to $29.00 and gave the company an "overweight" rating in a report on Thursday, April 21st. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $23.50.

Insider Transactions at Calumet Specialty Products Partners

In other Calumet Specialty Products Partners news, Chairman Stephen P. Mawer acquired 9,251 shares of Calumet Specialty Products Partners stock in a transaction dated Friday, August 12th. The stock was acquired at an average cost of $16.11 per share, for a total transaction of $149,033.61. Following the completion of the transaction, the chairman now owns 137,233 shares in the company, valued at approximately $2,210,823.63. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, Chairman Stephen P. Mawer bought 9,251 shares of the business's stock in a transaction on Friday, August 12th. The stock was purchased at an average cost of $16.11 per share, for a total transaction of $149,033.61. Following the completion of the transaction, the chairman now directly owns 137,233 shares of the company's stock, valued at approximately $2,210,823.63. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Scott Obermeier bought 6,350 shares of the business's stock in a transaction on Tuesday, August 9th. The stock was purchased at an average price of $15.95 per share, with a total value of $101,282.50. Following the completion of the transaction, the executive vice president now directly owns 48,143 shares of the company's stock, valued at $767,880.85. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 25,852 shares of company stock worth $415,170. Company insiders own 2.91% of the company's stock.